ULTRAGENYX PHARMACEUTICAL IN
RARENASDAQ🏆 #1684 by market capEarnings Nov 3US Equity
$26.75▼ $0.21 (−0.78%)
Live1h▲ 0.8%
24h▼ 0.8%
7d▲ 7.3%
14d▲ 7.0%
30d▼ 19.4%
1y▼ 4.8%
🏦Market Cap
$2.63B
Small Cap
📈Revenue Growth (YoY)
+20.1%
Healthy
📊Gross Margin
83.1%
High
💵FCF Margin
-68.3%
Thin
⚖️P/S Ratio
3.6x
Fair
Otter Score
50
Weak
Earnings
Q3 · 2026Reported 2026-08-04Earnings Per Share
Actual
-0.90
Expected
-1.22
beat
+26.20%
YoY +23.10%
Revenue
Actual
$214.00M
Expected
$183.08M
beat
+16.90%
YoY +28.50%
Consensus estimates
Recent quarters
Q3 2026
-0.90
beat
Q2 2026
-1.84
miss
Q1 2026
-1.29
miss
Q4 2025
-1.81
miss